Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with tacrolimus

Molecular Genetics and Metabolism

Volumn 105, Issue 3, 2012, Pages 525-527

  Tavira, Beatriz ^a   Coto, Eliecer ^a,h   Torres, Armando ^b,g   Diáz Corte, Carmen ^a   Diáz Molina, Beatriz ^a   Ortega, Francisco ^a,g,h   Arias, Manuel ^c,g   Diáz, Juan M ^d   Selgas, Rafael ^e,g   López Larrea, Carlos ^a,g   Ruiz Ortega, Marta ^f   Ortiz, Alberto ^f   González, Elena ^e   Campistol, Josep M ^g   Alvarez, Victoria ^a   Alonso, B ⁱ   Diaz M ⁱ   Corao, A I ⁱ   Gomez, E ⁱ   Rodriguez Lambert J L ⁱ   Moris C ⁱ   Bernardo, M J ⁱ   Rodrigo, E ⁱ   Silva, I ⁱ   Baltar, J M ⁱ   Rodriguez Pastore I ⁱ   Ortega, T ⁱ   Lopez Hoyos M ⁱ   Perez Carreno E ⁱ   Porrini, E ⁱ   Jimenez C ⁱ   De La Fuente, L ⁱ   Simoes Dos Santos, L ⁱ   more..

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d FUNDACIÓ PUIGVERT   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h Fundacion Renal Lnigo Alvarez de Toledo   (Spain)

ⁱ NONE

Author keywords

Genetic association; KCNJ11; Postransplant diabetes

Indexed keywords

INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84858293871     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.12.020     Document Type: Article

References (20)

1. Balla A., Chobanian M. New-onset diabetes after transplantation: a review of recent literature. Curr. Opin. Organ Transplant. 2009, 14:375-379.
2. Rodrigo E., Piñera C., de Cos M.A., Sánchez B., Ruiz J.C., Fernández-Fresnedo G., Palomar R., González-Cotorruelo J., Gómez-Alamillo C., de Castro S.S., de Francisco A.L., Arias M. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transpl. Int. 2005, 18:1152-1157.
3. Kang E.S., Kim M.S., Kim C.H., Nam C.M., Han S.J., Hur K.Y., Ahn C.W., Cha B.S., Kim S.I., Lee H.C., Kim Y.S. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea. Transplantation 2009, 88:693-698.
4. Ghisdal L., Baron C., Le Meur Y., Lionet A., Halimi J.M., Rerolle J.P., Glowacki F., Lebranchu Y., Drouet M., Noel C., El Housni H., Cochaux P., Wissing K.M., Abramowicz D., Abramowicz M. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 2009, 20:2459-2467.
5. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., Prokunina-Olsson L., Ding C.J., Swift A.J., Narisu N., Hu T., Pruim R., Xiao R., Li X.Y., Conneely K.N., Riebow N.L., Sprau A.G., Tong M., White P.P., Hetrick K.N., Barnhart M.W., Bark C.W., Goldstein J.L., Watkins L., Xiang F., Saramies J., Buchanan T.A., Watanabe R.M., Valle T.T., Kinnunen L., Abecasis G.R., Pugh E.W., Doheny K.F., Bergman R.N., Tuomilehto J., Collins F.S., Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
6. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
7. Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M., Andersen G., Ng D.P., Holmkvist J., Borch-Johnsen K., Jorgensen T., Sandbaek A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M., Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K., Kawamori R., Tai E.S., Pedersen O., Kamatani N., Kadowaki T., Kikkawa R., Nakamura Y., Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 2008, 40:1098-1102.
8. Zhou D., Zhang D., Liu Y., Zhao T., Chen Z., Liu Z., Yu L., Zhang Z., Xu H., He L. The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. J. Hum. Genet. 2009, 54:433-435.
9. Yang L., Zhou X., Luo Y., Sun X., Tang Y., Guo W., Han X., Ji L. Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals. Mol. Biol. Rep. 2012, 39:645-659.
10. Fischer A., Fisher E., Mohlig M., Schulze M., Hoffmann K., Weickert M.O., Schueler R., Osterhoff M., Pfeiffer A.F., Boeing H., Spranger J. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts. Diabetes Care 2008, 31:87-89.
11. Edghill E.L., Flanagan S.E., Ellard S. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11. Rev. Endocr. Metab. Disord. 2010, 11:193-198.
12. Fridlyand L.E., Ma L., Philipson L.H. Adenine nucleotide regulation in pancreatic beta-cells: modeling of ATP/ADP-Ca2+ interactions. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E839-E848.
13. Fuhrer D.K., Kobayashi M., Jiang H. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes. Metab. 2001, 3:393-402.
14. Schwanstecher C., Meyer U., Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 2002, 51:875-879.
15. Tavira B., Coto E., Diaz-Corte C., Ortega F., Arias M., Torres A., Diaz J.M., Selgas R., Lopez-Larrea C., Campistol J.M., Alvarez V. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. Clin. Chem. Lab. Med. 2011, 49:825-833.
16. Tavira B., Coto E., Diaz-Corte C., Ortega F., Arias M., Torres A., Diaz J.M., Selgas R., Lopez-Larrea C., Campistol J.M., Ruiz-Ortega M., Alvarez V. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Clin. Transplant. 2011, 25:E284-E291.
17. Yang J., Hutchinson I.I., Shah T., Min D.I. Genetic and clinical risk factors of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Transplantation 2011, 91:1114-1119.
18. Ashcroft F.M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J. Clin. Invest. 2005, 115:2047-2058.
19. Schwanstecher C., Neugebauer B., Schulz M., Schwanstecher M. The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic beta-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes 2002, 51:S363-S367.
20. Florez J.C., Jablonski K.A., Kahn S.E., Franks P.W., Dabelea D., Hamman R.F., Knowler W.C., Nathan D.M., Altshuler D. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007, 56:531-536.